Use of HMG fragment as antiinflammatory agents

Details for Australian Patent Application No. 2002309829 (hide)

International Classifications

Event Publications

19 December 2002 Complete Application Filed

Priority application(s): 60/291,034 15.05.01 US

1 May 2003 Application Open to Public Inspection

Published as AU-B-2002309829

15 March 2007 Change of Name(s) of Applicant(s), Section 104

University of Pittsburgh - of the Commonwealth System of Higher Education; The General Hospital Corporation; North ShoreLong Island Jewish Research Institute The name of the applicant has been changed to The General Hospital Corporation; University of Pittsburgh - of the Commonwealth System of Higher Education; The Feinstein Institute for Medical Research

23 August 2007 Application Accepted

Published as AU-B-2002309829

20 December 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.